BGIM
SSAAW

Boussard & Gavaudan Investment Management’s Science Strategic Acquisition Corp. Alpha Warrant SSAAW Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio SSAAW Stock Details SSAAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-66,666
Closed -$3 – 151
2022
Q3 		$3 Hold
66,666
– – ﹤0.01% 142
2022
Q2 		$6 Hold
66,666
– – ﹤0.01% 129
2022
Q1 		$18 Hold
66,666
– – ﹤0.01% 64
2021
Q4 		$37K Hold
66,666
– – ﹤0.01% 136
2021
Q3 		$47 Hold
66,666
– – ﹤0.01% 125
2021
Q2 		$57K Buy
+66,666
New +$50.2K 0.01% 96

Boussard & Gavaudan Investment Management's SSAAW Position: Q4 2022 in Review

Boussard & Gavaudan Investment Management sold out of Science Strategic Acquisition Corp. Alpha Warrant (SSAAW) in Q4 2022, closing a stake of 66,666 shares — an estimated $3 sold.

Boussard & Gavaudan Investment Management first reported a position in SSAAW in Q2 2021 and held it in 6 quarters. The position peaked at $57K in Q2 2021. 0 funds tracked by Wall St. Rank hold SSAAW as of Q4 2022.

  • Boussard & Gavaudan Investment Management reported no remaining Science Strategic Acquisition Corp. Alpha Warrant position as of Q4 2022 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 66,666 Science Strategic Acquisition Corp. Alpha Warrant shares in Q4 2022, an estimated $3.
  • Boussard & Gavaudan Investment Management first reported a position in Science Strategic Acquisition Corp. Alpha Warrant in Q2 2021 and held it in 6 quarters.
  • Boussard & Gavaudan Investment Management's Science Strategic Acquisition Corp. Alpha Warrant position peaked at $57K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Warrant as of Q4 2022.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.